HomeNYSE:PFE

NYSE:PFE

Pfizer’s Multiple Myeloma Drug Elrexfio Receives EU Approval

Pfizer’s Multiple Myeloma Drug Elrexfio Receives EU Approval

December 11, 2023

Pfizer’s Multiple Myeloma Treatment Elrexfio Receives Approval in the EU

Pfizer’s Multiple Myeloma Treatment Elrexfio Receives Approval in the EU

December 11, 2023

FDA Approves Pfizer’s Braftovi + Mektovi for Lung Cancer

FDA Approves Pfizer’s Braftovi + Mektovi for Lung Cancer

October 13, 2023

Pfizer Stock Does Not Indicate the Obesity Drug’s Blockbuster Potential, According to Cantor

Pfizer Stock Does Not Indicate the Obesity Drug’s Blockbuster Potential, According to Cantor

May 23, 2023